Home › NDC Lookup › RxCUI directory › RxCUI 484152

Chlorothiazide 500 MG Injection — RxCUI 484152

RxNorm drug concept · Semantic clinical drug
RxCUI 484152 Semantic clinical drug · SCD ● Current RxNorm concept 8 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI484152
Official nameChlorothiazide 500 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aschlorothiazide (as chlorothiazide sodium) 0.5 GM Injection
FDA products mapped8
Package NDCs mapped8
Reported Medicaid activity (SDUD)73 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Chlorothiazide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a water pill — it helps your kidneys flush out extra salt and fluid that's building up in your body. Depending on the form you're taking, it treats fluid retention (edema) fro...
  • What exactly is chlorothiazide supposed to do for me?
  • You'll take it by mouth, usually once or twice a day. Your doctor might also put you on an every-other-day or a few-days-per-week schedule — that actually helps prevent your electr...
  • How and when should I take the oral suspension (liquid)?
📖 Read our full Chlorothiazide guide →

🕸️ Concept Web — How Chlorothiazide 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Chlorothiazide 500 MG Injection RxCUI 484152

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Chlorothiazide 2396
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Chlorothiazide Injection 1731061
    • Chlorothiazide Injectable Product 1153867
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Chlorothiazide 500 MG 317325

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Chlorothiazide 500 MG SCDC · 317325
  • Chlorothiazide Injection SCDF · 1731061
  • Chlorothiazide Injectable Product SCDG · 1153867

📦 FDA Products & Package NDCs

8 products · 8 package NDCs
8 package NDCs map to RxCUI 484152 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00517-1820-01 1 VIAL in 1 CARTON (0517-1820-01) / 18 mL in 1 VIAL Chlorothiazide Sodium American Regent, Inc. 2015-04-01
25021-0305-20 1 VIAL in 1 CARTON (25021-305-20) / 18 mL in 1 VIAL chlorothiazide sodium Sagent Pharmaceuticals 2015-10-12
25021-0305-66 1 VIAL in 1 CARTON (25021-305-66) / 18 mL in 1 VIAL chlorothiazide sodium Sagent Pharmaceuticals 2019-12-15
47335-0330-40 1 VIAL, SINGLE-DOSE in 1 CARTON (47335-330-40) / 18 mL in 1... CHLOROTHIAZIDE SODIUM Sun Pharmaceutical Industries, Inc. 2016-08-25
63323-0658-20 1 VIAL in 1 BOX (63323-658-20) / 18 mL in 1 VIAL Chlorothiazide Fresenius Kabi USA, LLC 2009-10-21
63323-0658-27 1 VIAL in 1 BOX (63323-658-27) / 18 mL in 1 VIAL Chlorothiazide Fresenius Kabi USA, LLC 2009-10-21
63323-0658-94 1 VIAL in 1 BOX (63323-658-94) / 18 mL in 1 VIAL Chlorothiazide Fresenius Kabi USA, LLC 2009-10-21
68083-0614-01 1 VIAL in 1 CARTON (68083-614-01) / 18 mL in 1 VIAL Chlorothiazide sodium Gland Pharma Limited 2024-10-03
Observed labelers: Fresenius Kabi USA, LLC (3) · Sagent Pharmaceuticals (2) · American Regent, Inc. (1) · Gland Pharma Limited (1) · Sun Pharmaceutical Industries, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J1205 Chlorothiazide sodium inj 7 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.